Assessment of HPV Risk Type in H&E-stained Biopsy Specimens of the Cervix by Microscopy Image Analysis

Appl Immunohistochem Mol Morphol. 2020 Oct;28(9):702-710. doi: 10.1097/PAI.0000000000000823.

Abstract

Objectives: The objective of this study was (a) to identify, by computer processing of digitized images of hematoxylin and eosin (H&E)-stained biopsy material of the cervix, differences in the structure of nuclei between high-risk (HR) and low-risk (LR) human papillomavirus virus (HPV) types and (b) to assess the HPV risk type by designing a decision-support system (DSS).

Materials and methods: Clinical material comprised H&E-stained biopsies from squamous intraepithelial lesions of 55 patients with polymerase chain reaction-verified HR-HPV (26 patients) or LR-HPV (29 patients) infection. From each patient's biopsy specimen, we digitized 1 region of interest, guided by the expert physician. After the segmentation of nuclei, we quantified from each nucleus 77 textural and morphologic features. We represented each patient by a 77-feature vector, the feature means of all nuclei, and we created 2 classes for HR-HPV and LR-HPV types. We carried out (a) a statistical analysis to determine features with statistically significant differences between the 2 classes and (b) a discriminant analysis, by designing a DSS, to estimate the HPV risk type.

Results: Statistical analysis revealed 40 features with between-classes statistically significant differences and discriminant analysis showed that the best DSS design achieved a high accuracy of about 93% in identifying the HPV risk type on data not used in the design of the DSS.

Conclusions: Nuclei of HR-HPV types were of higher intensity, contained larger structures, had higher edges, were coarser, rougher, had higher contrast, were larger, and attained more irregular shapes. The proposed DSS indicates that discrimination of HPV risk type from images of H&E-stained biopsy material of the cervix is promising.

MeSH terms

  • Adolescent
  • Adult
  • Biopsy
  • Cervix Uteri / pathology*
  • Clinical Decision-Making
  • Diagnostic Imaging
  • Eosine Yellowish-(YS)
  • Female
  • Hematoxylin
  • Humans
  • Microscopy / methods*
  • Papillomaviridae / physiology*
  • Papillomavirus Infections / diagnosis*
  • Papillomavirus Infections / pathology
  • Risk
  • Staining and Labeling
  • Uterine Cervical Neoplasms / diagnosis*
  • Uterine Cervical Neoplasms / pathology
  • Young Adult

Substances

  • Eosine Yellowish-(YS)
  • Hematoxylin